• A transformed global enterprise for an HIV vaccine

      Tatoud, Roger; Snow, William; Esparza, José (Wiley-Blackwell, 2021-11-21)
      In this viewpoint, we revisit the early days of the Global HIV Vaccine Enterprise (the Enterprise) and explore how the COVID-19 vaccine development effort could inform a future transformation of an organization that has supported the vaccine R&D field since 2005 (Table 1), first as an alliance of stakeholders, and now as a convener hosted at the IAS – the International AIDS Society.